|

Gemcitabine Hydrochloride for Injection Clinical Trials

16 actively recruiting trials

No change since May 2026

Also known as: Gemcitabine Hydrochloride, NSC 613327

Pipeline

Phase 2: 3Phase 3: 10Phase 1/2: 3

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.3
  • Shanghai Yizhong Pharmaceutical Co., Ltd.2
  • Jiangsu Alphamab Biopharmaceuticals Co., Ltd2
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
  • BeBetter Med Inc2

Indications

  • Cancer16
  • Breast Cancer5
  • Biliary Tract Cancers (BTC)1
  • Advanced or Metastatic Urothelium Cancer1
  • Metastatic Breast Cancer (MBC)1

Other16 trials

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Phase 2
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Phase 3
A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
Phase 3
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Phase 3
A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer
Phase 2
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
Phase 3
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Phase 1/2
A Study of SHR-A1811 in Subjects With Ovarian Cancer
Phase 3
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Phase 3
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Phase 1/2
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Phase 1/2
Cosiporfin Sodium for Injection Photodynamic Therapy
Phase 2
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Phase 3
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.